Pradaxa Lawsuits Claim Drug is Dangerous, Defective

November 5, 2013

Important Information

Attorneys working with ClassAction.org are no longer reviewing claims for this case. The information here is for reference only. A list of open investigations can be viewed here.

Comments |

At A Glance

This Alert Affects
Patients who experienced internal bleeding while taking Pradaxa.
Injuries
Internal bleeding in the kidneys, gastrointestinal tract, and brain.
Manufacturer
Boehringer Ingelheim Pharmaceuticals
What is Pradaxa?
Pradaxa (dabigatran etexilate) is a blood thinner used to reduce the risk of stroke in patients with atrial fibrillation.
FDA Warning
On December 7, 2011, the FDA issued a safety announcement regarding Pradaxa, warning of "serious bleeding events" and urging patients to consult their healthcare professionals if bleeding or unusual bruising occurred.
Type of Lawsuit
Mass Tort